News Announcement

Panacea Biotec: Board Meeting Intimation for Approving The Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter And Half Year Ended September 30 2019

PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and half year ended September 30 2019.

Further pursuant to Regulations 46(2) & 47(1) of the SEBI LODR Regulations notice of the said meeting is also being sent for publication in newspapers and uploaded on the website of the Company.

Further with reference to our earlier announcement dated September 28 2019 intimating the Closure of Trading Window pursuant to the Companys Code of Conduct for Prevention of Insider Trading under SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time we would like to inform that the trading window of the Company shall remain closed for all Designated Persons of the Company and Material Subsidiaries of the Company till November 16 2019.

This is for your kind information and record please.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month